Clinical trial

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

NCT07293247

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Chemotherapy Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Immunotherapy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Intensity-Modulated Radiation Therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Computed Tomography Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Magnetic Resonance Imaging Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Fludeoxyglucose F-18 Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Biospecimen Collection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-10-14

PhasePHASE2

Conditions

Lung Non-Small Cell Carcinomaunresolved

Interventions

ChemotherapyDRUG

ImmunotherapyOTHER

Intensity-Modulated Radiation TherapyRADIATION

Computed TomographyPROCEDURE

Magnetic Resonance ImagingPROCEDURE

Fludeoxyglucose F-18OTHER

Biospecimen CollectionPROCEDURE

Sponsors & collaborators

Alliance for Clinical Trials in Oncologylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

PittsburghPennsylvania, United States5 PeoriaIllinois, United States3 DuluthMinnesota, United States3 New YorkNew York, United States2 PortlandOregon, United States2 The BronxNew York, United States2 SyracuseNew York, United States2 FargoNorth Dakota, United States2 Sioux FallsSouth Dakota, United States2 DecaturIllinois, United States2 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07293247 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.